RecallDepth
Class II Terminated

25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10

Company
Pfizer Inc.
Recall Initiated
November 27, 2019
Posted
December 18, 2019
Recall Number
D-0577-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
77,100 syringes
Firm Location
New York, NY, United States

Reason for Recall

Labeling: Incorrect or Missing Lot and/or expiration date.

Distribution

Nationwide within the United States including Puerto Rico.

Lot / Code Info

Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls